𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population

✍ Scribed by Michal Bronstein; Anne Pisanté; Benjamin Yakir; Ariel Darvasi

Publisher
Springer
Year
2008
Tongue
English
Weight
266 KB
Volume
124
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mucolipidosis type IV: Novel MCOLN1 muta
Mucolipidosis type IV: Novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population
✍ Ruth Bargal; Nili Avidan; Tzvia Olender; Edna Ben Asher; Marcia Zeigler; Annick 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

The gene MCOLN1 is mutated in Mucolipidosis type IV (MLIV), a neurodegenerative, recessive, lysosomal storage disorder. The disease is found in relatively high frequency among Ashkenazi Jews due to two founder mutations that comprise 95% of the MLIV alleles in this population [Bargal et al., 2000].

The frequency of mucolipidosis type IV i
The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations
✍ Gideon Bach; Michael B.T. Webb; Ruth Bargal; Marcia Zeigler; Joseph Ekstein 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Mucolipidosis type IV (MLIV) is a neurodegenerative lysosomal storage disorder that occurs in an increased frequency in the Ashkenazi Jewish (AJ) population. The frequency of the disease in this population has been established by the testing of 66,749 AJ subjects in the Dor Yeshorim program, a uniqu